Navigation Links
Study reviews health risks, economic burden of migraine
Date:2/2/2009

Falls Church, Va. February 02, 2009 A new study published in Value in Health reviews the economic burden of migraine in the U.S. and recent clinical findings of the health risks of this neurological condition. This study traces the history of economic articles published on migraine using the PubMed MEDLINE database and archival searches of relevant articles to identify possible health risks associated with migraines that warrant further study.

Migraine affects millions of individuals worldwide. Sufferers experience substantial decreases in functioning and productivity, results which in turn translate into diminished quality of life for individuals, financial burdens for health care systems and substantial lost work time that impacts individuals, employers, and societies alike. Migraine is a condition most prevalent in individuals between the ages of 25 and 55, generally the most productive years of a person's life.

Migraine is often perceived as a condition that imposes a minimal burden on society and the health care system. This misperception persists in part because the disorder is episodic and rarely causes long-term physical disability. Because it is under-diagnosed and under-treated, analyses of claims data underestimate the condition's prevalence and economic impact.

Recent clinical studies suggest that migraine may be a progressive disease with cardiovascular, cerebrovascular and long-term neurologic effects. Suffering from migraines may also be a risk factor for brain lesions. Additionally, studies following those who suffer from migraine with aura (sensory, motor or visual disturbances that can precede or accompany the headache) have shown these individuals to be twice as likely as the general population to develop major cardiovascular disease and suffer stroke. If such findings are confirmed, treatments, approaches and economic evaluations of migraine treatment may require major reconsideration.

Epidemiologic studies have recently indicated that 4 percent to 5 percent of the general population suffers from chronic daily migraine headache, a condition characterized by 15 or more headache days per month, and that transformed migrainethe transformation of episodic migraine to the chronic form of the disorderaccounts for approximately half of these patients.

Currently, most physicians do not think of migraine as they do illnesses such as diabetes, hypertension, asthma or rheumatoid arthritis. Nevertheless, migraine may need to be reexamined from a similar perspective as a chronic illness for which preventive therapy is important to delay or reduce more serious forms or complications.


'/>"/>

Contact: Sean Wagner
medicalnews@bos.blackwellpublishing.net
781-388-8550
Wiley-Blackwell
Source:Eurekalert

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
(Date:6/24/2016)... ... ... a crisis. Her son James, eight, was out of control. Prone to extreme mood shifts ... upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife ... and say he was going to kill them. If we were driving on the ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... "The World Market for Companion Diagnostic Tests" report to ... World Market for Companion Diagnostics The World ... diagnostic and personalized medicine diagnostics. Market analysis in the report ... Diagnostics Test Market (In Vitro Diagnostic Kits) by Region (N. ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
Breaking Medicine Technology: